普通人群及透析、肝硬化、肥胖患者男性乳腺发育的定量CT评估
回顾性纳入506例急诊创伤后行胸腹部CT的男性及45例血液透析、50例肝硬化患者,测量乳腺组织直径。普通男性乳腺组织直径22 mm、28 mm、36 mm分别对应第90、95、97.5百分位;乳腺组织直径与体重指数无关(r = -0.031)。血液透析和肝硬化患者乳腺组织直径超过22 mm、28 mm、36 mm的百分比更高(P < .0001)。作者提出影像学男性乳腺发育可定义为直径22 mm、28 mm或36 mm。
要点
- 普通男性乳腺组织直径22 mm、28 mm、36 mm分别对应第90、95、97.5百分位,可作为影像学男性乳腺发育的定量参考。
- 血液透析和肝硬化患者乳腺组织直径超过上述阈值的百分比更高(P < .0001),肥胖与乳腺组织直径无关(r = -0.031)。
核心结论
- 乳腺组织直径是评估男性乳腺发育的简单可靠定量工具,可确定普通人群各年龄段的男性乳腺发育发生率;影像学男性乳腺发育可定义为22 mm、28 mm或36 mm(分别对应第90、95、97.5百分位);影像学男性乳腺发育与肥胖无关,与肝硬化和透析相关。
研究设计与样本
- 回顾性研究,纳入506例因创伤至急诊科并接受胸腹部CT检查的男性,另纳入45例血液透析患者和50例肝硬化患者(接受胸部CT);计算所有研究人群的男性乳腺发育发生率和大小。
关键影像表现/征象
- 普通男性人群乳腺组织直径的第90、95、97.5累积百分位分别为22 mm、28 mm、36 mm。
- 乳腺组织直径与体重指数不相关(r = -0.031)。
- 血液透析患者和肝硬化患者乳腺组织直径超过22 mm、28 mm、36 mm的百分比更高(P < .0001)。
诊断标准与关键数值
- 普通男性人群乳腺组织直径22 mm、28 mm、36 mm分别对应第90、95、97.5累积百分位。
- 作者提出影像学男性乳腺发育可定义为乳腺组织直径22 mm、28 mm或36 mm(分别对应第90、95、97.5百分位)。
临床应用与阅片要点
- 作者认为乳腺组织直径可作为评估男性乳腺发育的简单可靠定量工具。
- 作者提出影像学男性乳腺发育可定义为22 mm、28 mm或36 mm(分别对应第90、95、97.5百分位)。
- 影像学男性乳腺发育与肥胖无关,与肝硬化和透析相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Gynecomastia is the benign enlargement of the male breast because of proliferation of the glandular component. To date, there is no radiological definition of gynecomastia and no quantitative evaluation of breast glandular tissues in the general male population. The aims of this study were to supply radiological-based measurements of breast glandular tissue in the general male population, to quantitatively assess the prevalence of gynecomastia according to age by decades, and to evaluate associations between gynecomastia and obesity, cirrhosis, and dialysis.
MATERIALS AND METHODS: This retrospective study included 506 men who presented to the emergency department following trauma and underwent chest-abdominal computed tomography. Also included were 45 patients undergoing hemodialysis and 50 patients with cirrhosis who underwent chest computed tomography. The incidence and size of gynecomastia for all the study population were calculated.
RESULTS: Breast tissue diameters of 22 mm, 28 mm, and 36 mm corresponded to 90th, 95th, and 97.5th cumulative percentiles of diameters in the general male population. Peaks of gynecomastia were shown in the ninth decade and in boys aged 13-14 years. Breast tissue diameter did not correlate with body mass index (r = -0.031). Patients undergoing hemodialysis and patients with cirrhosis had higher percentages (P < .0001) of breast tissue diameters above 22 mm, 28 mm, and 36 mm.
CONCLUSIONS: Breast tissue diameter is a simple and reliable quantitative tool for the assessment of gynecomastia. This method provides the ability to determine the incidence of gynecomastia by age in the general population. Radiological gynecomastia should be defined as 22 mm, 28 mm, or 36 mm (90th, 95th, and 97.5th percentiles, respectively). Radiological gynecomastia is not associated with obesity, but is associated with cirrhosis and dialysis.
引用
- Klang E, Kanana N, Grossman A, et al. Quantitative CT Assessment of Gynecomastia in the General Population and in Dialysis, Cirrhotic, and Obese Patients. Acad Radiol. 2018. PMID: 29326049. doi:10.1016/j.acra.2017.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。